Sign Up

Home of Hepatology7 rue Daubin1203 GenevaSwitzerland+41 22 807 03 60easloffice@easloffice.eu© 2025 EASL. All rights reserved.Website by Soto.Privacy Policy | Cookie Policy | Terms & Conditions | Cyber Security Explore offerUnlock the full potential of being part of the EASLcommunity. As a member, you’ll gain access toexclusive resources, reduced event fees, top-tierjournals, and professional development opportunitiesdesigned to support your career in hepatologyBecome a memberNurses & Allied Health ProfessionalsLink titleYoung InvestigatorsLink titleBasic ScienceLink titleTitle here Lorem ipsum At the heart of EASL is a diverse and dynamic international community of professionals dedicated to advancing hepatology.Discover how you can get involved and make an impact.Whether you're a member, a Young Investigator, a nurse or allied health professional, or focused on basic science, there's a place for you here. Explore the different pathways to connect, grow and contribute, from membership benefits to tailored programmes and scientific networksLorem ipsum dolor sit ipsum CommunitySign In / Sign UpResourcesWhat We DoAbout Us Partnerships
Flyout Menu
Main Menu

Rethinking Hepatitis B: Discussions with Patients – Adapting to Expanding Treatment Guidelines

By /

Faculty: Ahmed Elsharkawy (Moderator), Markus Cornberg (Faculty), Sital Shah (Faculty), Thomas Tu (Faculty), Su Wang (Faculty)

       Gilead-logo

This EASL Studio is supported by Aligos Therapeutics, Gilead Sciences Europe Ltd., and GSK
EASL has received no input from Aligos Therapeutics, Gilead Sciences Europe Ltd or GSK with regards to the content of this programme. 

Scroll to Top

Search EASL